Ethan Dmitrovsky

This inventor holds 21 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent. Top assignees: Dartmouth College, Io Therapeutics, Inc., Koebenhavns Universitet (University of Copenhagen). Active years: 2009-2025.

USPTO Granted Patents = 21 (Patent Applications = 6)

% Patents Active = 66.7

CIPO Patents = 1

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 25(Granted Patents)

Company Filing History:

Io Therapeutics, Inc.

patents

1 out of 1

Koebenhavns Universitet (University of Copenhagen)

patent

4. 1 out of 3

Lo Therapeutics, Inc.

patents

5. 1 out of 131

University of Copenhagen

patents

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12383521 - Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists (2025-08-12),

2. 11793781 - Autoimmune disorder treatment using RXR agonists (2023-10-24),

3. 11576881 - Autoimmune disorder treatment using RXR agonists (2023-02-14),

4. 11547684 - Autoimmune disorder treatment using RXR agonists (2023-01-10),

5. 11246845 - Autoimmune disorder treatment using RXR agonists (2022-02-15),

6. 11166927 - Autoimmune disorder treatment using RXR agonists (2021-11-09),

7. 10945976 - Autoimmune disorder treatment using RXR agonists (2021-03-16),

8. 10695307 - Autoimmune disorder treatment using RXR agonists (2020-06-30),

9. 10653650 - Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists (2020-05-19),

10. 10285960 - Autoimmune disorder treatment using RXR agonists (2019-05-14),

11. 10201512 - Autoimmune disorder treatment using RXR agonists (2019-02-12),

12. 10034845 - Autoimmune disorder treatment using RXR agonists (2018-07-31),

13. 9056135 - MicroRNA biomarkers for human breast and lung cancer (2015-06-16),

14. 8697668 - Compositions and methods for preventing and treating cancer via modulating UBE1L, ISG215 and/or UBP43 (2014-04-15),

15. 8417324 - Fluorescence lifetime spectrometer (FLS) and methods of detecting diseased tissue (2013-04-09),

Title: The Innovative Journey of Inventor Ethan Dmitrovsky

Introduction: Ethan Dmitrovsky, a distinguished inventor based in Hanover, NH (US), has made significant contributions to the field of innovations and patents with his groundbreaking work.

Latest Patents: Ethan Dmitrovsky holds several patents in the medical field, focusing on novel treatments for cancer and other diseases. His recent patents include advancements in targeted therapies and precision medicine.

Career Highlights: With a background in oncology and molecular biology, Ethan Dmitrovsky has had a remarkable career trajectory. He has served as a leading researcher in renowned institutions, pioneering new approaches to personalized medicine.

Collaborations: Throughout his career, Ethan Dmitrovsky has collaborated with top pharmaceutical companies, research institutions, and universities worldwide. His partnerships have led to the development of cutting-edge technologies and life-saving treatments.

Conclusion: In conclusion, Ethan Dmitrovsky stands as a visionary inventor whose work continues to shape the landscape of medical innovations. His dedication to advancing healthcare through patents and inventions is truly commendable.